Steps for Epilepsy

Wake Forest University Health Sciences26 enrolled

Overview

The purpose of this research study is to evaluate the feasibility of a 12-week, telehealth delivered, step-goal based physical activity intervention in people with epilepsy. The study team will also evaluate the physical activity profiles of people with epilepsy both at rest and when engaged in physical activity and gather information on the effect of the intervention on epilepsy and epilepsy associated comorbidities.

This is a randomized, controlled, pilot trial to assess the feasibility of a 12-week telehealth delivered, step-goal based physical activity intervention in people with epilepsy. This will be carried out using a 2-arm, parallel group design with a healthy living education control. Participants will undergo formal exercise testing to establish a baseline fitness level and safety of participation. They will wear Garmin activity tracker on their wrist throughout the study to track their steps. During a 4 week baseline period, we will gather data on baseline physical activity levels and seizure frequency. Participants will then be randomized to either the intervention group or a healthy living education control group. The intervention group will undergo a 12-week, telehealth delivered, step goal based physical activity intervention with a goal of ultimately achieving at least 8,000 steps per day. The intervention will utilize social cognitive theory to encourage lasting behavior changes and have weekly group coaching sessions with a trained health and behavior change provider. The control group will receive education every two weeks but will not be given a coaching plan. The study will evaluate adherence to the intervention, sustainability of the intervention over 12 weeks after the formal coaching program ends, and acceptability of the intervention. The study will also investigate the physical activity profile of people with epilepsy both at rest and when asked to participate in physical activity with a self-selected intensity and bout duration. The study will collect information on the effect of the intervention on seizures, mood, quality of life, sleep, fitness, and heart-rate variability, as well as other epilepsy relevant outcomes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Epilepsy

Interventions

12-week Physical Activity ProgramBEHAVIORAL

Participants in this arm will undergo a 12-week physical activity program aimed to achieve the equivalent of 8,000 steps per day (56,000 weekly steps). Includes weekly meetings with a trained health coach.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 or older * Focal or generalized epilepsy, as determined clinically by a WFBH epileptologist with no significant consideration of an alternative diagnosis * Access to a smartphone with application capabilities * Internet access or cellular data plan to attend virtual sessions * Able to ambulate independently Exclusion Criteria: * Diagnosis of nonepileptic or psychogenic spells * Seizures associated with falls with injury (such as atonic seizures) * Medical conditions that would limit ability to participate in an exercise intervention including: Stage III or IV Congestive Heart Failure (CHF); End-stage Renal Disease; Severe dementia or significant cognitive impairment that precludes participation in the intervention or limits ability to follow the study protocol; Uncontrolled hypertension (HTN) defined as systolic blood pressure greater than 180 mmHg and diastolic blood pressure greater than 110 mmHg at rest; Severe arthritis, amputations, or orthopedic problems that limit ambulatory ability * Currently pregnant or plan to become pregnant during the study period (16 weeks) * An active Central Nervous System (CNS) infection, demyelinating disease, degenerative neurologic disease or any CNS disease deemed to be progressive during the course of the study that may confound the interpretation of the study results * Any clinically significant psychiatric illness, psychological, or behavioral problems that would interfere with the subject's ability to participate in the study. * Unwilling or unable to comply with all study visits and procedures * Participants who have \<75% complete days of seizure recording in the study diary or step data via the Garmin device will not be randomized.

Locations (1)

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, United States

Outcomes

Primary Outcomes

Proportion of Participants Who Achieve Their Assigned Step Goal - Adherence

As measured by average daily steps via the Garmin device over the last 4 weeks of the intervention period.

Time frame: Week 12 to Week 16

Proportion of Participants Who Achieve Their Assigned Step Goal - Sustainability

As measured by average daily steps via the Garmin device over the last 4 weeks of the maintenance period, will be calculated and 95% binomial confidence intervals generated.

Time frame: Week 24 to Week 28

Secondary Outcomes

Time Spent Sedentary

Time spent sedentary during the last week of baseline as measured by the Garmin watch.

Time frame: Week 4

Time Spent in Light Intensity Activity

Time spent in light intensity in the last week of baseline as measured by the Garmin watch.

Time frame: Week 4

Time Spent in Moderate Intensity Activity

Time spent in moderate intensity in the last week of baseline as measured by the Garmin watch.

Time frame: Week 4

Time Spent in Vigorous Intensity Activity

Time spent in vigorous intensity in the last week of baseline as measured by the Garmin watch.

Time frame: Week 4

Exit Survey

The scale ranges from 4-20 with higher scores indicating greater satisfaction with the study.

Time frame: Week 28

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.